Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
11
2019
accepted:
02
11
2020
entrez:
20
11
2020
pubmed:
21
11
2020
medline:
5
1
2021
Statut:
epublish
Résumé
This systematic review aimed to ascertain the diagnostic accuracy (sensitivity and specificity) of screening tests for early detection of type 2 diabetes and prediabetes in previously undiagnosed adults. This systematic review included published studies that included one or more index tests (random and fasting tests, HbA1c) for glucose detection, with 75-gram Oral Glucose Tolerance Test (or 2-hour post load glucose) as a reference standard (PROSPERO ID CRD42018102477). Seven databases were searched electronically (from their inception up to March 9, 2020) accompanied with bibliographic and website searches. Records were manually screened and full text were selected based on inclusion and exclusion criteria. Subsequently, data extraction was done using standardized form and quality assessment of studies using QUADAS-2 tool. Meta-analysis was done using bivariate model using Stata 14.0. Optimal cut offs in terms of sensitivity and specificity for the tests were analysed using R software. Of 7,151 records assessed by title and abstract, a total of 37 peer reviewed articles were included in this systematic review. The pooled sensitivity, specificity, positive (LR+) and negative likelihood ratio (LR-) for diagnosing diabetes with HbA1c (6.5%; venous sample; n = 17 studies) were 50% (95% CI: 42-59%), 97.3% (95% CI: 95.3-98.4), 18.32 (95% CI: 11.06-30.53) and 0.51 (95% CI: 0.43-0.60), respectively. However, the optimal cut-off for diagnosing diabetes in previously undiagnosed adults with HbA1c was estimated as 6.03% with pooled sensitivity of 73.9% (95% CI: 68-79.1%) and specificity of 87.2% (95% CI: 82-91%). The optimal cut-off for Fasting Plasma Glucose (FPG) was estimated as 104 milligram/dL (mg/dL) with a sensitivity of 82.3% (95% CI: 74.6-88.1%) and specificity of 89.4% (95% CI: 85.2-92.5%). Our findings suggest that at present recommended threshold of 6.5%, HbA1c is more specific and less sensitive in diagnosing the newly detected diabetes in undiagnosed population from community settings. Lowering of thresholds for HbA1c and FPG to 6.03% and 104 mg/dL for early detection in previously undiagnosed persons for screening purposes may be considered.
Identifiants
pubmed: 33216783
doi: 10.1371/journal.pone.0242415
pii: PONE-D-19-32907
pmc: PMC7678987
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
hemoglobin A1c protein, human
0
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0242415Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
J Assoc Physicians India. 2005 Apr;53:299-305
pubmed: 15987016
Diabetes Care. 2010 Jan;33(1):101-3
pubmed: 19837792
J Diabetes Res. 2015;2015:396505
pubmed: 26347060
J Diabetes Investig. 2015 Jan;6(1):44-50
pubmed: 25621132
Diabetes Technol Ther. 2016 Apr;18(4):226-32
pubmed: 26894547
Diabetes Care. 2011 Apr;34(4):944-9
pubmed: 21335372
Biomed Environ Sci. 2013 Mar;26(3):155-62
pubmed: 23425797
PLoS One. 2017 Feb 13;12(2):e0171315
pubmed: 28192447
Prev Med. 2013 Oct;57(4):345-50
pubmed: 23777673
J Diabetes Res. 2016;2016:6195494
pubmed: 27597979
Diabetes Care. 2009 Jul;32(7):1327-34
pubmed: 19502545
BMJ. 2012 Jul 09;345:e4514
pubmed: 22777029
Ann Intern Med. 2008 Dec 16;149(12):889-97
pubmed: 19075208
J Clin Epidemiol. 2020 Jun;122:142-152
pubmed: 32058069
PLoS One. 2015 Oct 16;10(10):e0134553
pubmed: 26474310
BMC Endocr Disord. 2013 Feb 25;13:8
pubmed: 23442875
Diabet Med. 2007 Apr;24(4):333-43
pubmed: 17367307
Diabetes Care. 2000 Oct;23(10):1563-80
pubmed: 11023153
Clin Chim Acta. 2015 Aug 25;448:215-9
pubmed: 26143642
BMC Infect Dis. 2016 Mar 25;16:140
pubmed: 27013465
J Diabetes. 2013 Sep;5(3):282-90
pubmed: 23452328
Sci Rep. 2018 Aug 20;8(1):12419
pubmed: 30127499
Diabetes Care. 2010 Mar;33(3):545-50
pubmed: 20007941
J Diabetes Complications. 2001 Jul-Aug;15(4):171-3
pubmed: 11457667
Diabetes Metab Syndr. 2017 Oct - Dec;11(4):251-255
pubmed: 27623517
Diabetes Metab Res Rev. 2013 Nov;29(8):680-92
pubmed: 23963843
JAMA. 1990 Jun 6;263(21):2893-8
pubmed: 2338751
Diabetes Res Clin Pract. 2002 Jan;55(1):35-43
pubmed: 11755477
PLoS One. 2017 Sep 8;12(9):e0184607
pubmed: 28886160
Ethn Dis. 2018 Feb 1;28(1):19-24
pubmed: 29467562
Eur J Clin Nutr. 2017 Jul;71(7):816-824
pubmed: 28422124
Am J Public Health. 1982 Jun;72(6):536-8
pubmed: 6803601
Lancet. 2017 Jun 3;389(10085):2239-2251
pubmed: 28190580
Acta Diabetol. 2003 Dec;40(4):181-6
pubmed: 14740278
Diabetes Res Clin Pract. 2014 Oct;106(1):11-8
pubmed: 24857263
Diabetes Res Clin Pract. 2002 Nov;58(2):139-48
pubmed: 12213356
Bol Oficina Sanit Panam. 1968 Oct;65(4):281-393
pubmed: 4234760
Diabetes Care. 2012 Feb;35(2):319-26
pubmed: 22238276
Diabetes Care. 2010 Dec;33(12):2626-8
pubmed: 20833866
Herz. 2016 May;41(3):175-83
pubmed: 27052353
BMJ Open Sport Exerc Med. 2020 Apr 27;6(1):e000772
pubmed: 32411383
PLoS One. 2016 Aug 25;11(8):e0161966
pubmed: 27560687
Scand J Clin Lab Invest. 2000 Oct;60(6):457-62
pubmed: 11129061
Endocrine. 2015 Mar;48(2):511-8
pubmed: 24895042
Diabetes Technol Ther. 2014 Dec;16(12):853-7
pubmed: 25014878
Diabetes Care. 2010 Mar;33(3):515-9
pubmed: 19903752
J Clin Epidemiol. 2016 Aug;76:89-98
pubmed: 26931285
Diabetes Care. 2010 Jan;33(1):61-6
pubmed: 19808928
Syst Rev. 2013 Oct 07;2:82
pubmed: 24099098
Diabetes Care. 2011 Jan;34(1):145-50
pubmed: 20978099
Diabetes Care. 1998 Jul;21(7):1138-45
pubmed: 9653609
BMC Endocr Disord. 2019 Jan 22;19(1):11
pubmed: 30670002
PLoS One. 2015 Mar 18;10(3):e0119510
pubmed: 25785585
Endocr Pract. 2016 Oct;22(10):1151-1160
pubmed: 27295013
BMC Med Res Methodol. 2016 Aug 12;16(1):97
pubmed: 27520527
J Endocrinol Invest. 2013 Jan;36(1):33-7
pubmed: 22453076
Diabet Med. 2013 Mar;30(3):e70-7
pubmed: 23199158
S Afr Med J. 2015 Jan 08;105(2):98-102
pubmed: 26242524
J Diabetes Investig. 2016 Sep;7(5):695-702
pubmed: 27181567
Epidemiol Rev. 2011;33:63-87
pubmed: 21624961
BMJ. 2017 Jan 4;356:i6538
pubmed: 28052845
Diabetes Care. 2009 Apr;32(4):641-3
pubmed: 19073758
Diabet Med. 2018 Mar;35(3):317-322
pubmed: 29230866
Diabetes. 1988 Jan;37(1):60-4
pubmed: 3335278
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Prim Care Diabetes. 2018 Jun;12(3):238-244
pubmed: 29370998
Curr Diab Rep. 2015 Apr;15(4):20
pubmed: 25721248
Lancet Diabetes Endocrinol. 2015 Aug;3(8):624-37
pubmed: 26109024
Int J Surg. 2010;8(5):336-41
pubmed: 20171303
Diabetes Res Clin Pract. 2007 Feb;75(2):241-5
pubmed: 16875755